Latest filing published 07 Mar 2024 for Teva Pharmaceutical Industries Ltd. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Eric Drape in Teva Pharmaceutical Industries Ltd, where the filings describe the role as senior executive. In total, 12 filings cover trades dated from 11 May 2021 to 5 March 2024.
Every open-market trade on record is a sale: 3 sales worth €2.5M. The rest of the record consists of 9 option exercises. Since January 2024: no purchases and 1 sale on the market.
On 7 March 2024 came the latest disclosure, an option exercise in Teva Pharmaceutical Industries Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations